Interferon-beta in multiple sclerosis. Can we control its costs?
Madgwick
T
T
D003363:Cost Control; D006801:Humans; D007155:Immunologic Factors / Q000191:economics* / Q000627:therapeutic use*; D016899:Interferon-beta / Q000191:economics* / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000191:economics*